OBI Phase 3 shows 40.5% fewer 30-day surgical site infections
OBI’s LANTERN Phase 3 study met its primary endpoint, reporting a 40.5% reduction in 30-day surgical site infections with nasal photodisinfection added to standard care. The study cites robust Bayesian and frequentist analyses and a strong safety profile.
5% reduction in 30-day surgical site infections when nasal photodisinfection was added to standard care, with results supported by robust Bayesian and frequentist analyses. The intervention was described as having a strong safety profile and broad-spectrum effic…